Juan Sanchez | Vice President-Corporate Communications and Investor Relations |
Sharon Mates | Chairman and Chief Executive Officer |
Mark Neumann | Chief Commercial Officer |
Larry Hineline | Chief Financial Officer |
Suresh Durgam | Chief Medical Officer |
Vardhman Chhajed | JPMorgan |
Leonid Timashev | RBC Capital Markets |
Andrew Tsai | Jefferies |
Charles Duncan | Cantor Fitzgerald |
Jeff Hung | Morgan Stanley |
Sumant Kulkarni | Canaccord Genuity |
Marc Goodman | SVB Leerink |
Umer Raffat | Evercore ISI |
Jason Gerberry | Bank of America |
Ash Verma | UBS |
David Amsellem | Piper Sandler |
Corinne Jenkins | Goldman Sachs |
Graig Suvannavejh | Mizuho Securities |
Good morning and welcome to Intra-Cellular Therapies First Quarter Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speaker presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today’s conference call is being recorded.
I would now like to turn the conference over to Dr.